In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation.
Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S, Peggs K, Verfuerth S, Pettengell R, Marsh JC, Schey S, Mahendra P, Morgan GJ, Hale G, Waldmann H, Ruiz de Elvira MC, Williams CD, Devereux S, Linch DC, Goldstone AH, MacKinnon S.
Kottaridis PD, et al. Among authors: mackinnon s.
Cytotherapy. 2001;3(3):197-201. doi: 10.1080/146532401753174025.
Cytotherapy. 2001.
PMID: 12171726
Clinical Trial.